Physician's Practice

JUNE 9, 2025

68: Hidden risks of prescribing GLP-1 drugs with Ericka L. **Financial Relationships with Pharmaceutical Companies (00:20:10)** Legal and ethical concerns for physicians with financial ties to GLP-1 drug manufacturers, including anti-kickback laws. Transform interactions into lasting connections. 65: Patient autonomy with Jeffrey A.

Management 52

Management Telemedicine Patients Insurance 52

GeriPal

MAY 5, 2022

If you want to take a deeper dive into this subject and read some of the articles we discussed in the podcast, check out the following: Hearing Loss: Effect on Hospice and Palliative Care Through the Eyes of Practitioners. COVID-19, masks, and hearing difficulty: Perspectives of healthcare providers. Transcript. This is Eric Widera.

IT 102

IT Screening Hospital Clinic 102

FDA Law

SEPTEMBER 13, 2021

A final OIG rule to change the structure of manufacturer rebates to Medicare Part D and Medicaid Managed Care plans and their PBMs is enmeshed in litigation and is likely to be at least postponed until 2026 (see our post ), and perhaps prevented from implementation altogether, by Congressional mandate. Court of Appeals (again, see our post ).

Manufacturing 98

Manufacturing Supply Chain Patient-Centered Utilities 98